China Regenerative Medicine International Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was HKD 46.04 million compared to HKD 34.34 million a year ago. Net income was HKD 11.19 million compared to HKD 1.1 million a year ago. Basic earnings per share from continuing operations was HKD 0.0392 compared to HKD 0.0039 a year ago.
For the six months, sales was HKD 100.09 million compared to HKD 86.26 million a year ago. Net income was HKD 12.76 million compared to HKD 2.22 million a year ago. Basic earnings per share from continuing operations was HKD 0.0447 compared to HKD 0.0078 a year ago.